These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3036315)

  • 1. Intensive anti-oxidant pretreatment retards motor nerve degeneration.
    Hall ED
    Brain Res; 1987 Jun; 413(1):175-8. PubMed ID: 3036315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylprednisolone preservation of motor nerve function during early degeneration.
    Hall ED; Wolf DL
    Exp Neurol; 1984 Jun; 84(3):715-20. PubMed ID: 6327356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of motor nerve function during early degeneration by the 21-aminosteroid anti-oxidant U74006F.
    Hall ED; Yonkers PA
    Brain Res; 1990 Apr; 513(2):244-7. PubMed ID: 2350694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial action of glucocorticoid treatment on neuromuscular transmission during early motor nerve degeneration.
    Hall ED; Riker WF; Baker T
    Exp Neurol; 1983 Feb; 79(2):488-96. PubMed ID: 6129995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of motor nerve terminal repetitive discharge by the 21-aminosteroid tirilazad: evidence of a neural calcium antagonist action.
    Hall ED; Yonkers PA
    Brain Res; 1998 Jan; 779(1-2):346-9. PubMed ID: 9473721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission.
    Hall ED; Von Voigtlander PF
    Neuropharmacology; 1987 Nov; 26(11):1573-9. PubMed ID: 2829047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review.
    Hall ED; Braughler JM
    Cent Nerv Syst Trauma; 1986; 3(4):281-94. PubMed ID: 3555850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid effects on the edrophonium responsiveness of normal and degenerating mammalian motor nerve terminals.
    Hall ED; Riker WF; Baker T
    Ann Neurol; 1977 Nov; 2(5):404-8. PubMed ID: 215074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication.
    Schaumburg HH; Wiśniewski HM; Spencer PS
    J Neuropathol Exp Neurol; 1974 Apr; 33(2):260-84. PubMed ID: 4362700
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of neuronal degeneration secondary to central nervous system trauma or ischemia.
    Hall ED; Yonkers PA
    J Neurotrauma; 1989; 6(4):227-8. PubMed ID: 2614850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activation of lipid peroxidation in early degeneration of motor nerve fibers and the effect of antioxidants on its development].
    Shalatonin VT; Petrasgevskaya NN; Chernova TO
    Patol Fiziol Eksp Ter; 1991; (5):45-6. PubMed ID: 1806894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor nerve terminals as the site of initial functional changes after denervation.
    Okamoto M; Riker WF
    J Gen Physiol; 1969 Jan; 53(1):70-80. PubMed ID: 4302630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional, pharmacologic, and ultrastructural correlates in degenerating rat motor nerve terminals.
    Drakontides AB; Riker WF
    Exp Neurol; 1978 Mar; 59(1):112-23. PubMed ID: 627259
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of pyronin on sprouting and regeneration of mouse motor nerves.
    Keynes RJ
    Brain Res; 1982 Dec; 253(1-2):13-8. PubMed ID: 7150964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo study of mechanism of propranolol-induced blockade or neuromuscular transmission.
    Patel VK; Jindal MN; Kelkar VV
    Indian J Physiol Pharmacol; 1974; 18(2):126-8. PubMed ID: 4370094
    [No Abstract]   [Full Text] [Related]  

  • 16. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of motor nerve terminals.
    Riker WF; Okamoto M
    Annu Rev Pharmacol; 1969; 9():173-208. PubMed ID: 4307019
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
    Ellis KO; Carpenter JF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition.
    Kawabuchi M; Cintra WM; Deshpande SS; Albuquerque EX
    Synapse; 1991 Jul; 8(3):218-28. PubMed ID: 1948671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of tetanus toxin on the motor end-plates of the mouse. An electron microscopic study.
    Duchen LW
    J Neurol Sci; 1973 Jun; 19(2):153-67. PubMed ID: 4351451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.